OQL-061

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameOQL-061
Drug Alias NameOQL-061
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsDiarrheaColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOnquality Pharmaceuticals
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiarrheaColitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A